PAPER Alhawarri MB, Dianita R, Razak KN, Mohamad S, Nogawa T, Wahab HA
SEARCH RESULTS
19932 RESULTS
PAPER Grossmann K
Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.
Int J Mol Sci. 2021 Apr 30;22(9) PubMed: 33946588PAPER Ahmad SS, Khan MB, Ahmad K, Lim JH, Shaikh S, Lee EJ, Choi I
Biocomputational Screening of Natural Compounds against Acetylcholinesterase.
Molecules. 2021 Apr 30;26(9) PubMed: 33946559PAPER Sharma VK, Singh TG, Garg N, Dhiman S, Gupta S, Rahman MH, Najda A, Walasek-Janusz M, Kamel M, Albadrani GM, Akhtar MF, Saleem A, Altyar AE, Abdel-Daim MM
Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?
Biomolecules. 2021 Apr 30;11(5) PubMed: 33946488PAPER Alabed S, Zhou H, Sariyer IK, Chang SL
Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease.
Int J Mol Sci. 2021 Apr 30;22(9) PubMed: 33946401PAPER Hanas JS, Hocker JR, Vannarath CA, Lerner MR, Blair SG, Lightfoot SA, Hanas RJ, Couch JR, Hershey LA
Distinguishing Alzheimer's Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis.
Brain Sci. 2021 Apr 30;11(5) PubMed: 33946285PAPER Rasmussen MK, Mestre H, Nedergaard M
Fluid Transport in the Brain.
Physiol Rev. 2021 May 5; PubMed: 33949874PAPER Lu Y, Gwee X, Chua DQ, Lee TS, Lim WS, Chong MS, Yap P, Yap KB, Rawtaer I, Liew TM, Pan F, Ng TP
Nutritional Status and Risks of Cognitive Decline and Incident Neurocognitive Disorders: Singapore Longitudinal Ageing Studies.
J Nutr Health Aging. 2021;25(5):660-667. PubMed: 33949634PAPER Turner K, Bartlett D, Grainger SA, Eddy C, Reyes A, Kordsachia C, Turner M, Stout JC, Georgiou-Karistianis N, Henry JD, Ziman M, Cruickshank T
Profiling Social Cognition in Premanifest Huntington's Disease.
J Int Neuropsychol Soc. 2021 May 5;:1-13. PubMed: 33949297PAPER Watt JA, Lane NE, Veroniki AA, Vyas MV, Williams C, Ramkissoon N, Thompson Y, Tricco AC, Straus SE, Goodarzi Z
Diagnostic accuracy of virtual cognitive assessment and testing: Systematic review and meta-analysis.
J Am Geriatr Soc. 2021 Jun;69(6):1429-1440. Epub 2021 May 4 PubMed: 33948937Jessica Young on iNDI Aims to Standardize Human Stem Cell Research
COMMENT The iPSC Neurodegenerative Disease Initiative (iNDI) is a herculean effort led by Mark Cookson and Michael Ward at the NIH to provide well-characterized hiPSC lines that harbor hundreds of mutations and/or variants that contribute to Alzheimer’s disease a
iNDI Aims to Standardize Human Stem Cell Research
RESEARCH NEWS 2021-05-06 Research News A large human stem-cell initiative is underway to help the field explore genetic variants for different forms of dementia. In the April 7 Neuron, Michael Ward, National Institute of Neurological Disorders and Stroke, and Mark Cookson at the
Douglas Galasko on iNDI Aims to Standardize Human Stem Cell Research
COMMENT This is an extremely helpful initiative that will have a huge impact on iPSc research in relation to AD and other neurodegenerative disorders. There are many advantages to studying human neurons and glial cells as models for these disorders. Rodent models
Simon Lee
Cornwall Partnership NHS Foundation TrustLiskeard, United Kingdom
PAPER Tupe-Waghmare P, Rajan A, Prasad S, Saini J, Pal PK, Ingalhalikar M
Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Eur Radiol. 2021 Nov;31(11):8218-8227. Epub 2021 May 4 PubMed: 33945022Current Filters
- Date Range : May 2020 to May 2021 x